ArticleAmerican journal of respiratory and critical care medicine2013
An official American Thoracic Society/European Respiratory Society statement: the role of the pulmonologist in the diagnosis and management of lung cancer.
Article in American journal of respiratory and critical care medicine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
28 citing papers in PubMed, 67 citations in OpenAlex.
- Review
- Molecular Diagnostic Yield and Safety Profile of Ultrasound-Guided Lung Biopsies: A Cross-Sectional Study.Cancers · 2024Article
- Inter- and intra-observer variability of radial-endobronchial ultrasound image interpretation for peripheral pulmonary lesions.Journal of thoracic disease · 2024Article
- Added value of EUS-B-FNA to bronchoscopy and EBUS-TBNA in diagnosing and staging of lung cancer.European clinical respiratory journal · 2024Review
- The Interdisciplinary Management of Lung Cancer in the European Community.Journal of clinical medicine · 2022Review
- Shape-Sensing Robotic-Assisted Bronchoscopy in the Diagnosis of Pulmonary Parenchymal Lesions.Chest · 2022Article
- Hospital-based multidisciplinary lung cancer care in Australia: a survey of the landscape in 2021.BMJ open respiratory research · 2022Article
- Intraoperative Lung Ultrasound (ILU) for the Assessment of Pulmonary Nodules.Diagnostics (Basel, Switzerland) · 2021Article
- A Multidisciplinary Lung Cancer Program: Does It Reduce Delay Between Diagnosis and Treatment?Lung · 2020Article
- Multidisciplinary care models for patients with lung cancer.Breathe (Sheffield, England) · 2020Review
- Accuracy of lung cancer staging in the multidisciplinary team setting.Translational lung cancer research · 2020Review
- Multidisciplinary team care in advanced lung cancer.Translational lung cancer research · 2020Review
- Stakeholder engagement to initiate lung cancer screening in an urban safety-net health system.Healthcare (Amsterdam, Netherlands) · 2020Article
- Fluoroscopy guided percutaneous biopsy in combination with bronchoscopy and endobronchial ultrasound in the diagnosis of suspicious lung lesions - the triple approach.European clinical respiratory journal · 2020Article
- Continuous professional development: elevating thoracic oncology education in Europe.Breathe (Sheffield, England) · 2019Article
- The clinical value of carcinoembryonic antigen for tumor metastasis assessment in lung cancer.PeerJ · 2019Article
- Safety of endobronchial ultrasound-guided transbronchial needle aspiration in patients with lung cancer within a year after percutaneous coronary intervention.Thoracic cancer · 2018Article
- Treatment of limited disease small cell lung cancer: the multidisciplinary team.The European respiratory journal · 2017Review
- Clinical Equipoise and Shared Decision-making in Pulmonary Nodule Management. A Survey of American Thoracic Society Clinicians.Annals of the American Thoracic Society · 2017Article
- Lung cancer and chronic obstructive pulmonary disease: From a clinical perspective.Oncotarget · 2017Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundLung cancer is a common problem seen by pulmonologists. The American Thoracic Society (ATS) and European Respiratory Society (ERS) are professional organizations whose memberships are composed of large numbers of pulmonologists. PURPOSE: This document describes the key role of pulmonologists in the prevention, early diagnosis, and management of lung cancer.
methodsA committee of ATS and ERS leaders and their oncology groups discussed the activities of pulmonologists in relation to lung cancer in various settings and reviewed available literature on the topic. The content of this statement was approved by the board of directors of both the ATS and ERS.
resultsOptimal lung cancer care requires a multidisciplinary team of specialists who care for a significant number of patients on a regular basis. Pulmonologists are responsible for and involved with patients from their initial diagnosis and staging through treatment and restaging. They are often involved with complications, palliative care, and end-of-life care, and thus have an important role in team leadership.
conclusionsLung cancer is a disease with high mortality, profound effects on the quality of the lives of patients and their families, and an enormous cost and impact on society. To treat lung cancer optimally, care must be prompt, multidisciplinary, and patient-centered. In the entire process, pulmonologists have a key role. Pulmonologists and their professional societies should also enhance lung cancer research and education to provide better treatment options and patient care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.